Biotech launches rarely stall on the science. They stall when brand, medical, legal, and regulatory read the core claims differently. I find that misalignment early, while it is still cheap to fix.
Founder led. 15+ years across Johnson & Johnson MedTech, McCann Health, and Publicis Worldwide.
When brand, medical, legal, and regulatory have not agreed on core claims before submission, the same problems show up:
Most of this is visible, and fixable, months before submission.
Makeni Bent’s Launch Messaging Alignment Workshop brings your cross-functional team to consensus in two days.
A two day working session that brings brand, medical, legal, and regulatory to one set of core claims before submission.
I run the room as a neutral outside facilitator, so the discussion stays on the claims and off internal politics. You leave with decisions, not meeting notes.
A one week launch delay costs far more than this workshop. I will help you size it for your own launch during the first call.
Who I Work With
This is designed for pre commercial and early commercial teams who are:
Running more than one launch? Ask about portfolio level alignment.
15+ years across global agencies and in house pharma and MedTech teams, focused on the moment where claims meet stakeholders.
Co led content migration strategy for seven MedTech companies into unified injmedtech.com platform. Managed cross functional coordination across brand, medical affairs, legal, and regulatory.
Agency side pharmaceutical marketing across oncology, rare disease, CNS, PAH, immunology, and vaccines, for global pharmaceutical clients. Navigated compliance driven messaging and stakeholder alignment on global brands.
MBA, Marketing Management, St. John's University (Tobin College of Business). BA, Political Science, University of Notre Dame.
Tell me where you are in the launch timeline and where messaging feels least aligned. I will reply with next steps.